Burden of illness and treatment attitudes among participants meeting Rome <scp>IV</scp> criteria for irritable bowel syndrome: A nationwide survey in the United States
This study provides insight into respondents' experiences of IBS symptoms, including the impact on daily activity, as well as satisfaction with control of symptoms and prescription and over-the-counter medications.
Authors
- Ceciel Rooker
- Yanqing Xu (ORCID: https://orcid.org/0000-0002-3990-7617)
- Robert Morlock (ORCID: https://orcid.org/0000-0002-8723-2562)
- Amy Morlock
- Rachel Dobrescu
- Katherine J. Kosch
- Brian E. Lacy (ORCID: https://orcid.org/0000-0003-4121-7970)
- Douglas C.A. Taylor
Institutions
- Ironwood Pharmaceuticals (United States) (US)
- Jacksonville College (US)
- AbbVie (United States) (US)
- Acumen (United States) (US)
- International Foundation for Functional Gastrointestinal Disorders (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Neurogastroenterology & Motility
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1111/nmo.14903
- Citations
- 11
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 5.10
Funders
- AbbVie
- Ironwood Pharmaceuticals, Incorporated